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Abstract
Significance: A growing body of clinical and experimental evidence has challenged the traditional under-
standing that only the adaptive immune system can mount immunological memory. Recent findings describe the
adaptive characteristics of the innate immune system, underscored by its ability to remember antecedent foreign
encounters and respond in a nonspecific sensitized manner to reinfection. This has been termed trained innate
immunity. Although beneficial in the context of recurrent infections, this might actually contribute to chronic
immune-mediated diseases, such as atherosclerosis.
Recent Advances: In line with its proposed role in sustaining cellular memories, epigenetic reprogramming has
emerged as a critical determinant of trained immunity. Recent technological and computational advances that
improve unbiased acquisition of epigenomic profiles have significantly enhanced our appreciation for the
complexities of chromatin architecture in the contexts of diverse immunological challenges.
Critical Issues: Key to resolving the distinct chromatin signatures of innate immune memory is a compre-
hensive understanding of the precise physiological targets of regulatory proteins that recognize, deposit, and
remove chemical modifications from chromatin as well as other gene-regulating factors. Drawing from a rapidly
expanding compendium of experimental and clinical studies, this review details a current perspective of the
epigenetic pathways that support the adapted phenotypes of monocytes and macrophages.
Future Directions: We explore future strategies that are aimed at exploiting the mechanism of trained im-
munity to improve the prevention and treatment of infections and immune-mediated chronic disorders. Anti-
oxid. Redox Signal. 29, 1023–1040.
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Introduction
Innate immunity is the first in line and one of the mostimportant components of host defense. Recently, a para-
digm shift has occurred through the discovery of memory
properties in innate immune cells (91, 106). In contrast to
adaptive immune responses, the innate immune system has
traditionally been viewed as primitive and generic, lacking the
ability to differentiate individual species of pathogen or the
quantity of encounters. However, an unequivocal body of
clinical and experimental evidence now argues for a shift in our
understanding of the innate immune system (91), underscored
by its capacity to confer broad immunological protection.
Innate immune cells, such as monocytes/macrophages and
natural killer cells (NK-cells), can recollect a previous for-
eign encounter and, therefore, mount immunological mem-
ory. This biological process of innate immune memory has
been called trained immunity (92), and it is illustrated by the
observation that stimulation of innate immune cells with a
pathogen augments the subsequent immune response to
similar or unrelated immunological stimuli (66, 106). The
enhanced immune response is associated with a profound
change in the intracellular metabolism and epigenetic regu-
lation at the level of histone modifications (4, 115).
Besides the primary function of the innate immune system
to mediate first-line host defense against a broad spectrum of
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pathogens and to regulate tissuehomeostasis, recent studies have
argued that functional reprogramming of innate immune cells
may also play an important role in immune-mediated diseases
(9, 134, 135). Monocytes and macrophages are involved in the
pathogenesis of many highly prevalent chronic disorders, in-
cluding insulin resistance (obesity as well as diabetes mellitus),
tumor growth, and autoimmune or autoinflammatory diseases
such as rheumatoid arthritis and inflammatory bowel disease.
Further, innate immune cells play a central role in the develop-
ment of atherosclerosis, a chronic low-grade inflammatory
condition of the vessel wall, with macrophages being the most
abundant immune cells in the atherosclerotic lesion that regu-
lates plaque progression and stability (28, 88). The involvement
of innate immune cells in atherosclerosis, as well as in other
immune-mediated diseases, illustrates the pivotal role of the
innate immune system in common inflammatory disorders with
a high medical and economic burden.
To exploit the concept of trained immunity to improve
vaccination strategies or prevent atherosclerosis and other
chronic inflammatory diseases, it is crucial to unravel the
underlying mechanism. This review provides a comprehen-
sive state-of-the-art framework on the intracellular events
that coordinate trained immunity, namely intracellular me-
tabolism and epigenetic rewiring of gene transcription. Un-
derstanding the specific immunometabolic pathways and
epigenetic signatures of innate immune memory is crucial for
the development of novel therapeutic approaches for infec-
tious and chronic inflammatory diseases.
Memories Are Not Just About the Past
Unlike acquired immunity, which primes the adaptive
immune system for an enhanced response to subsequent en-
counters with the same pathogen, innate immune memory
instructs an altered future response that is nonspecific. Non-
specific immunological memory has long been known to
occur in plants (33) and invertebrate animals (103, 105, 114),
both of which lack an adaptive immune system, suggesting an
ancient biological process (93). The first indication of the
potential importance of this phenomenon for vertebrate host
defense came from the broad protection conferred against
unrelated diseases by pioneering vaccination programs. As
early as the 1930s, Bacillus Calmette–Gue´rin (BCG), one of
the world’s most administered vaccines against Myco-
bacterium tuberculosis, was found to greatly improve the
survival of infants beyond the tuberculosis mortality burden
(3, 20, 38, 75, 113, 129). The nonspecific beneficial effects of
BCG vaccination were further demonstrated by randomized
clinical trials reporting reduced mortality from various in-
fections in low-birth-weight children in Africa (1, 13).
Perhaps the most striking example in humans supporting a
nonspecific training of the immune system was a series of
studies revealing a heightened ex vivo immune response to
the fungal pathogen Candida albicans in human volunteers
recently vaccinated with BCG (66), consistent with previous
reports of BCG-mediated protection against disseminated
candidiasis in experimental animals (15, 130). The enhanced
immune response was detected not only for the lymphocyte-
derived IFNc but also for monocyte-derived TNFa and IL6.
Further, the heterologous protection conferred by BCG
training was replicated in mice with known deficiencies in
adaptive immune responses (66).
Appreciation for the importance of innate immune mem-
ory has since expanded beyond vaccines to include various
microbe-associated molecular patterns (MAMPs). For ex-
ample, protection against lethal C. albicans infection in mice
by prior administration of a nonlethal dose is dependent on
the enhanced proinflammatory and microbicidal function of
trained monocytes and macrophages (106). Similar effects
are observed for human primary monocytes trained in vitro
with the C. albicans cell wall component b-1,3-(d)-glucan
(b-glucan), which show an enhanced secondary response to
stimulation with various Toll-like receptor (TLR) agonists
such as the bacterial lipoprotein Pam(3)CSK4 (TLR2) and
lipopolysaccharide (LPS) endotoxin (TLR4). This in vitro
model (8) exemplifies the main properties of trained immu-
nity: Infection with one pathogen augments the subsequent
immune response to unrelated immunological stimuli. In
striking contrast, primary stimulation by a high dose of LPS
has been long known to induce a persistent refractory state
with reduced capacity to respond to restimulation by a pro-
cess called LPS-induced tolerance (40). Conceptually also a
form of innate immune memory, inappropriately activated
immune tolerance is responsible for the immunoparalysis
induced by Gram-negative sepsis (36, 142). The adapted
phenotypes induced in vitro are highly reproducible across
cells prepared from unrelated donors and indicative of a
specific program of cell differentiation (115). The distinct
and opposing functional programs of training and tolerance
provide a useful contrast for understanding the extremes of a
spectrum of adaptive characteristics that can be acquired by
the innate immune system in response to diverse immuno-
logical challenges (Fig. 1).
FIG. 1. Innate immune memory underlies a spectrum of
adaptive characteristics that are acquired in response to
diverse immunological challenges. Monocyte (Mo) memo-
ries of past encounters with microbial and nonmicrobial
products can elicit vastly different responses to future expo-
sures on differentiation to macrophages (Mu). Trained im-
munity, induced by BCG, b-glucan, or oxLDL, defines an
immunological memory that calibrates an enhanced non-
specific response to subsequent infections by enhancing the
inflammatory and antimicrobial properties of innate immune
cells. In contrast, primary stimulation with LPS induces a
persistent refractory state known as tolerance, with a mark-
edly reduced capacity to respond to restimulation. b-glucan,
b-1,3-(d)-glucan; BCG, Bacillus Calmette–Gue´rin; LPS, li-
popolysaccharide; oxLDL, oxidized low-density lipoprotein.
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Trained immunity is a double-edged sword
Despite its benefits in the context of infections, long-term
activation of the innate immune system may play a mala-
daptive role in the pathogenesis of chronic inflammatory
diseases (59). One example of such a disease is atheroscle-
rosis, the result of a chronic, low-grade vascular inflamma-
tion in which the immune system plays a central role. A
complex interplay between endothelial cells, smooth muscle
cells, and circulating immune cells creates a proinflammatory
microenvironment in the vascular wall supporting the for-
mation of an atherosclerotic plaque (25). In this process, the
most abundant inflammatory cells are monocytes and mac-
rophages. By migrating into the vessel wall, monocytes de-
termine early plaque development, and after differentiation
into macrophages they ingest lipid particles to become foam
cells (59). Moreover, local damage-associated molecular
patterns such as modified low-density lipoprotein (LDL)
particles and proteoglycans stimulate membrane-bound re-
ceptors such as TLR2 and TLR4 (154). The subsequent se-
cretion of proinflammatory cytokines and chemokines further
fuels the proinflammatory environment that is associated
with the development, progression, and (in)stability of ath-
erosclerotic plaques (59).
Training of human primary monocytes with MAMPs in-
duces a marked elevation in the production of pro-
inflammatory cytokines and chemokines that are strongly
implicated in the development and progression of athero-
sclerotic plaques (135). Vaccination with BCG accelerates
atherosclerosis in rabbits fed a cholesterol-rich diet (69). In
contrast, other studies have reported a protective effect in
atherosclerosis-prone mice (100, 131), which might be due to
its cholesterol-lowering action. Perhaps most compelling are
recent observations that nonmicrobial products, including
lipoproteins that are known drivers of cardiovascular disease,
can also induce trained immunity (Table 1). In vitro stimu-
lation of human primary monocytes with a low concentration
of oxidized low-density lipoprotein (oxLDL) programs a
sustained atherogenic macrophage phenotype that is char-
acterized by elevated expression of CD36 and SR-A scav-
enger receptors leading to enhanced foam cell formation, as
well as amplified proinflammatory cytokine production and
matrix metalloprotease expression (9). Similarly, brief ex-
posure to lipoprotein(a) induces a proinflammatory pheno-
type inmonocytes that are restimulated in vitro (134). Indeed,
circulating monocytes isolated from patients with symp-
tomatic atherosclerosis exhibit a proinflammatory phenotype
compared with cells isolated from healthy controls (10). This
effect was also observed in patients with an increased car-
diovascular risk due to elevated circulating levels of lipo-
protein(a) (134).
These findings convey the concept that trained immunity is
a biological process with broad implications for cardiovas-
cular disease (59). Such a model implies that monocytes are
stimulated by environmental signals in the circulation that
could induce epigenetic reprogramming, thereby increasing
their responsiveness to secondary stimulation, for instance
within the arterial wall or atherosclerotic plaque. The ability
Table 1. Inducers of Innate Immune Memory in Monocytes
Primary stimulus
Type of immune
response
Cellular metabolism
in trained cells References
BCG Trained immunity [ Aerobic glycolysis Kleinnijenhuis et al. (66)
Arts et al. (4)[ Oxidative phosphorylation
[ Glutamine metabolism
Candida albicans Trained immunity Quintin et al. (106)
Saccharomyces cerevisiae
via fungal chitin
Trained immunity Rizzetto et al. (111)
b-1,3-(d)-glucan Trained immunity [ Aerobic glycolysis
Y Oxidative phosphorylation
Cheng et al. (24)
Saeed et al. (115)
Arts et al. (5)
oxLDL Trained immunity [ Glycolysis Bekkering et al. (9)
Lipoprotein(a) Trained immunity Van der Valk et al. (134)
Fumarate Trained immunity Arts et al. (5)
TLR-agonists
TLR 4: LPS Trained immunity/
tolerance
Novakovic et al. (97)
TLR 2: Pam3CSK4 Immunotolerance
TLR 3: poly(I:C) Trained immunity/
tolerance
Foster et al. (40)
Ifrim et al. (50)
Lachmandas et al. (68)TLR 5: flagellin Trained immunity/
tolerance
Cytosolic receptors
NOD2 (muramyl dipeptide, MDP) Trained immunity Ifrim et al. (50)
NOD1
(l-Ala-c-d-Glu-mDAP, Tri-DAP)
Trained immunity
Cytokines/chemokines
GM-CSF, IL-3 Trained immunity Borriello et al. (16)
IFNy Immune priming Hoeksema et al. (47)
BCG, Bacillus Calmette–Gue´rin; LPS, lipopolysaccharide; oxLDL, oxidized low-density lipoprotein; TLR, Toll-like receptor.
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for macrophages to adopt unique properties as a function of
their microenvironment raises important considerations for
macrophage populations in atherosclerotic lesions that are
hypoxic, as well as rupture-prone versus stable plaques.
Further, accelerated atherosclerosis remains the principal
cause of morbidity and premature mortality in patients with
diabetes mellitus (81), and a role for trained immunity in
diabetic versus normoglycemic environments warrants ex-
ploration (59, 135). Several other factors associated with
metabolic disease such as free fatty acids, uric acid, and ad-
vanced glycation end-products elicit inflammatory responses
in monocytes via pattern recognition receptor stimulation,
raising the unexplored possibility that they too could induce
functional reprogramming and innate immune memory in the
context of cardiovascular complications (30, 135).
Cellular metabolism determines the phenotype
of innate immune cells
The extensive range of physiological macrophage functions
in host defense and maintenance of tissue homeostasis neces-
sitates a broad spectrum of precisely regulated states of mac-
rophage activation. Although it has long been appreciated that
changes in oxygen and glucose consumption accommodate the
metabolic requirements of activated macrophages, the impor-
tance of intracellular metabolism for shaping the immune re-
sponse has only recently emerged (98). Moreover, engagement
of distinct metabolic pathways not only follows energy re-
quirements but also distinguishes and supports discrete mac-
rophage phenotypes. This metabolic reprogramming is best
exemplified by the polarization of classically activated (M1
or M[IFNc]) and alternatively activated (M2 or M[IL-4])
macrophages. Paralleling their respective pro- and anti-
inflammatory phenotypes, these subtypes are characterized by
distinct arginine metabolism as well as by differences in fatty
acid synthesis and usage [recently reviewed by Van den
Bossche et al. (133)]. Although glycolytic metabolism is up-
regulated across both polarized states, activation of the pentose
phosphate pathway (PPP) is only observed in classically acti-
vated macrophages, where it supports inflammatory responses
by generating amino acids for protein synthesis, nucleotides for
proliferation, as well as NADPH for the production of reactive
oxygen species that are necessary for phagocytic killing (98).
Though energetically less efficient than mitochondrial oxi-
dative phosphorylation (OXPHOS), the relatively rapid ex-
pandability of glycolysis allows faster production of ATP to
meet cellular requirements (90, 98). In alternatively activated
macrophages, these biochemical processes remain coupled:
Enhanced glycolytic generation of pyruvate fuels the tricar-
boxylic acid (TCA) cycle and parallels the induction of
OXPHOS (132). This contrasts sharply with inflammatory
macrophages, which are characterized by impaired OXPHOS
and anabolic repurposing of the TCA cycle (98, 133). This
metabolic shift is comparable to the Warburg effect charac-
teristic of cancer metabolism that amends tumor cells to
hypoxic environments by upregulating glycolytic gene ex-
pression via the hypoxia-inducible factor 1 alpha (HIF1a)
transcription factor (TF) (125, 141). Further, instead of feeding
into the TCA cycle to ultimately fuel OXPHOS, pyruvate is
fermented to lactate by HIF1a-dependent pathways. A similar
process drives the glycolytic switch in inflammatory macro-
phages despite the availability of oxygen (98, 132).
Cellular metabolism orchestrates innate immune memory.
A metabolic switch comparable to that of classically ac-
tivated macrophages underlies the adapted phenotype in-
duced by b-glucan training. Stimulation of human monocytes
with b-glucan induces glycolysis paralleling elevated glucose
consumption and increased pyruvate to lactate conversion
(24). Moreover, markedly reduced oxygen consumption in
b-glucan-trained macrophages indicates a concomitant re-
duction in OXPHOS (24). Recent studies reported long-term
upregulation of glycolytic rate-limiting enzymes in circulat-
ing monocytes from individuals vaccinated with BCG and
demonstrated that genetic variation in hexokinase 2 and
phosphofructokinase modulates induction of trained immu-
nity (4). Contrasting the classical Warburg switch induced by
b-glucan, the immunometabolic profile of BCG training is
characterized not only by increased glycolysis and lactate
production but also by augmented oxygen consumption (4).
However, inhibition of the electronic transport chain did not
alter the reprogramming of macrophages in BCG training,
demonstrating the secondary role of OXPHOS in develop-
ment of the adapted phenotype (4). By contrast, inhibition of
glycolysis with 2-deoxyglucose abrogated BCG training.
Further, inhibition of the Akt/mechanistic target of rapa-
mycin (mTOR)/HIF1a pathway at several stages abolished
training by b-glucan and BCG in vitro as well as experi-
mental animals (4, 24). Emphasizing the relevance of this
pathway in humans, administration of the antidiabetic drug
and indirect mTOR inhibitor metformin decreased the ability
for circulating monocytes to mount a trained response ex vivo
to b-glucan exposure in healthy individuals (5). Interestingly,
the PPP was also found to be upregulated in b-glucan-trained
cells. However, evidence so far suggests that the role of the
PPP in trained immunity is relatively small, since inhibition
of this pathway had no effect on the adapted phenotype (5).
The relevance of this metabolic rewiring in the context of
atherosclerosis is illustrated by the consistent finding that
glycolytic enzymes are upregulated inmonocytes andmonocyte-
derived macrophages that are isolated from patients with
established atherosclerosis (10, 119).
Despite the metabolic skewing of b-glucan-trained mac-
rophages toward glycolysis, concentrations of the TCA
cycle metabolites citrate, succinate, malate, fumarate, and
2-hydroxyglutarate are increased in comparison to naive
macrophages (5). This suggested that the TCA cycle was
not entirely adjourned and led to the speculation that these
specific metabolites were being replenished through glu-
taminolysis (5). Indeed, increased glutamine metabolism
was one of the consistent immunometabolic changes in
macrophages trained with b-glucan and BCG (4, 5, 24),
and it plays an important role in immune activation (120).
Demonstrating the importance of this process, the gluta-
minase inhibitor BPTES blocked the induction of trained
immunity by b-glucan (5) and BCG (4) in vitro and in
experimental animal models (5).
Immunometabolic pathways that are important for the
functional reprogramming of immune cells extend beyond
those involved in glucose metabolism and OXPHOS. Cells
trained with b-glucan displayed upregulation of more than
half of the genes involved in cholesterol biosythesis, identi-
fying this pathway together with glutaminolysis and glycol-
ysis as one of the most essential for innate immune training
(5). Underlining the importance of the cholesterol synthesis
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pathway even further, treatment with the HMG-CoA-
reductase atorvastatin attenuated b-glucan-induced innate
immune training in a murine model (5). Since, next to sterols,
the essential lipids in the human cell membrane are phos-
pholipids and glycolipids, fatty acid synthesis is also an im-
portant pathway in immune cell function (133). Indeed,
recent data indicate that inflammatory stimuli such as LPS
and cytokines trigger an increase in fatty acid synthesis in
macrophages (5). However, in contrast to the abrogation of
training when cholesterol synthesis was inhibited, blockade
of fatty acid synthesis did not alter the proinflammatory
macrophage phenotype induced by b-glucan training (5).
Molecular mechanisms of macrophage memory. For a
monocyte, memories of past encounters with microbial
products can be truly transformative insofar as they can elicit
vastly different future responses to microbial ligands. The
gross implication of training or tolerance is a fundamental
phenotypic shift involving changes to major metabolic and
signaling pathways that facilitate the overall cellular mem-
ory. Underlying much of this reprogramming are widespread
transcriptional changes associated with metabolic pathways,
many of which occur early in the training regimen and pre-
cede the adapted phenotype (5).
Because distinct cell types and subtypes of multicellular
organisms arise from identical genetic material, gene control
and expression are fundamental determinants of differentia-
tion and phenotype. However much remains to be understood
about how genetic information is interpreted by individual
cells in health and disease. Only when we unravel the DNA
strands to appreciate the constituent assembly of chromatin
can we begin to recognize the complexity of genome orga-
nization and regulation (29).
Chromatin reorganization and innate immune memory
Epigenetic regulation of gene expression. Gene tran-
scription is tightly controlled by the interplay and long-range
communication of regulatory events at gene promoters that are
proximal to the transcription start site and distal genetic ele-
ments called enhancers (21). Accessibility of the DNA to
protein TFs and other transcriptional machinery at these reg-
ulatory regions is essential for gene expression. The dynamic
polymer of DNA and nucleosomal histone proteins known as
chromatin facilitates functional compartmentalization of the
genome to assemble structurally open, transcriptionally per-
missive configurations or condensed, repressive domains (57).
Since the initial description of the nucleosome particle as the
repeating unit of chromatin in 1977 (39), it has become in-
creasingly clear that core nucleosome components are distin-
guishable by post-translational chemical modification and
instructive of chromatin architecture (54, 136).
Histone modifications influence chromatin structure and
function. The octameric nucleosome is composed of four
core histone proteins: two H3 and H4 homodimers and two
H2A/H2B heterodimers, encircled by*147 bp of DNA (57).
Unstructured N-terminal histone tails that extend from nu-
cleosomes are substrate for post-translational enzymatic
modifications, which are cooperatively associated with var-
ious states of transcriptional competency and chromatin or-
ganization. Amid a vast repertoire of histone modifications
(73), acetylation (lysine residues) and methylation (arginine
and lysine residues) are the most broadly studied and ex-
tensively characterized (Fig. 2). The capacity for histone
modifications to designate functional genomic regions and
support transcriptional processes significantly amplifies the
information potential of the genetic code through mecha-
nisms that modulate chromatin structure and function. Their
influence on higher order chromatin accessibility is pre-
dominantly facilitated by establishing high-affinity bind-
ing sites for the recruitment of chromatin readers: core
transcriptional machinery, as well as multisubunit protein
complexes that actively restructure, relocate, install, or evict
nucleosomes (7).
Histone acetylation. Histone acetylation, for example at
lysine-9 (H3K9ac) and lysine-27 (H3 histone-lysine-27
acetylation [H3K27ac]) of H3 histones, almost exclusively
demarcates transcriptional competency (35). In addition to
promoting open chromatin architecture by neutralizing
the electrostatic charges on the histone tail and subsequently
altering interactions with adjacent nucleosome compo-
nents (55), acetylated histones are recognized and bound by
bromodomains—a structural motif found in specialized
chromatin reader proteins (116). Components ofmany histone
acetyltransferase (HAT) complexes harbor bromodomains,
which anchor the HAT complexes to acetylated chromatin,
allowing them to propagate the acetyl signature to adjacent
nucleosomes. Similarly, the bromodomain components of
ATP-dependent chromatin remodeling complexes are critical
for their recruitment to acetylated promoters (55). Another
class of histone-acetyl readers known as the bromodomain
and extra-terminal (BET) domain-containing family of pro-
teins can regulate gene expression by recruiting TFs as well
as chromatin remodeling complexes, and they are increasingly
implicated in transcriptional responses that are associated with
inflammation (59) and innate immunity (94, 110). Histone
modifications are reversible, and their presence on the chro-
matin is determined by opposing activities of enzymatic
writers and erasers. Histone deacetylase (HDAC) enzymes
remove acetyl groups from histone tails. Thus, HAT/HDAC
activity balance is an important determinant of gene regula-
tion, and it has accordingly emerged as a potential therapeutic
target for the treatment of various diseases (48, 62, 108, 127).
Histone methylation. Contrasting histone acetylation, the
position of the modified residue within the histone tail deter-
mines the functional readout of histone methylation. Reg-
ulatory elements of repressed genes are often characterized
by H3 histones that are methylated at lysine-9 and lysine-27.
Conversely, methylation of lysine-4 and lysine-36 is associ-
ated with the assembly of transcriptionally permissive chro-
matin structures. Enzymes that catalyze the transfer (lysine
methyltransferase [KMT]) and removal (lysine demethylase
[KDM]) of histone methylation demonstrate remarkable speci-
ficity toward amino acid positions within the histone tail
(51). Further, specific enzymes and complexes determine the
extent of individual lysine methylation: Mono- (m1), di- (m2),
or trimethylated (m3) histone lysine residues are differen-
tially distributed across chromatin and attributed discrete
functional roles in gene regulation. Transcriptional activity
positively correlates with the degree of H3 histone-lysine-4
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trimethylation (H3K4m3) at gene promoters (11). On the
other hand, monomethylation of this residue (H3 histone-
lysine-4 monomethylation [H3K4m1]) is a stereotypical fea-
ture of enhancers (6). Specialized protein domains, including
the chromodomain, tudor domain, malignant brain tumor
(MBT) domain, and the plant homeodomain (PHD) finger
domain, interpret methylated histones by recruiting various
chromatin-remodeling complexes (49, 128).
DNA methylation regulates gene expression. The epi-
geneticmethylmodification is unique in theway that in addition
to histones, it can also be written directly to the DNA template.
Again, the genomic location of the modification is key to the
functional outcome. Postreplicativemethylation of the 5-carbon
ring of cytosine nucleotides (5-methylcytosine, 5mc) immedi-
ately adjacent to guanine residues (5¢-cytosine-phosphate-
guanine-3¢ dinucleotide [CpG]) is primarily associated with
promoter silencing by two main mechanisms. First, 5mc is
mechanistically interpreted by proteins possessing the methyl-
CpG-binding domain, which, in turn, recruit transcriptional re-
pressors and chromatin remodeling complexes to establish
transcriptionally incompetent chromatin (43). Second, 5mc can
physically modulate the binding of TFs to gene regulatory ele-
ments (52). On the other hand, 5mc regulates gene splicing,
transcriptional elongation, and distal regulatory activities of
highly transcribed genes (53). Recent advances in methyl-
capture and sequencing technologies have propelled efforts to
characterize the DNA methylome across various tissues and
disease states, including myeloid differentiation (2, 37), mac-
rophage polarization (140), and cytokine production (151).
Epigenetic cross-talk. The emerging picture of epigenetic
regulation is one of remarkable complexity. Protein complexes
that read chromatin marks can further recruit certain classes of
epigenetic enzymes that cooperatively shape the chromatin
landscape. For example, binding of heterochromatin protein 1
(HP1) via its chromodomain to H3K9m2/3 promotes further
repressivemethyl marks by enlisting additional KMTs, as well
as DNA methyltransferases (41, 124). Together with the ac-
tivities of short (micro RNAs [miRNAs]) and long noncoding
RNA (lncRNA), histone and DNA modifications are collec-
tively defined as epigenetic (80). Through complex interactions
with TF networks and other transcriptional machinery, epige-
netic modifications collaboratively support the functional ex-
change between repressed and active states of chromatin to
contextualize gene expression.
Chromatin modifications associated with macrophage
differentiation and identity
Epigenome-wide variations underlying cellular function
and fate are definable at unprecedented resolution by current
FIG. 2. Post-translational che-
mical modifications distinguish
between chromatin architecture
and transcriptional competency.
As the repeating structural unit of
chromatin, the nucleosome consists
of*147bp ofDNAwrapped around
an octamer of the core histone pro-
teins H2A, H2B, H3, and H4. Un-
structured N-terminal histone tails
are substrate for a variety of post-
translational modifications, which
are dynamicallywritten to and erased
from specific amino acid residues by
specialized enzymes. Shownhere are
lysinemodifications that occur on the
tails of H3 and H4 histones. Histone
lysine acetylation (orange hexagons)
is ubiquitously associated with tran-
scriptional competency and is regu-
lated by the competing activities of
HAT and deacetylase (HDAC) en-
zymes. By contrast, the extent of
modification and the position of the
modified residue within the histone
tail determine the functional readout
of histone lysinemethylation ( purple
hexagons). The influence of histone
modifications on higher order chro-
matin accessibility is predomi-
nantly facilitated by establishing
high-affinity binding sites for the
recruitment of protein complexes
that actively remodel chromatin.
HAT, histone acetyltransferase;
HDAC, histone deacetylase; K, ly-
sine; KDM, lysine demethylase;
KMT, lysine methyltransferase.
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analytical technologies. To this end, the importance of histone
modifications to cellular identity is underscored by the massive
reconfiguration of lysine methylation and acetylation patterns
at gene regulatory elements during naive monocyte to mac-
rophage differentiation (97, 115). Crucially, the intersection of
transcriptome and epigenome profiles revealed a positive
correlation between transcriptionally permissive H3 histone
modifications and the activity of regulatory elements (115).
The most dynamic of these changes were observed for H3
acetylation, with one report describing approximately equal
numbers of promoters exhibiting significant enrichment or
depletion of H3K27ac (97, 115).
A similar pattern of H3K27ac was observed at distal en-
hancer regions on differentiation, with 1894 and 2142 regions
displaying significant loss and gain of this modification, re-
spectively (115), in accordance with the function of enhancers
as key determinants of cell identity, especially within the my-
eloid lineage. The complements of active enhancer elements
in a given tissue are typically co-occupied by combinations of
lineage-determining TFs enforcing tissue- and cell-type-specific
programs of gene expression (45, 99). Enhancers are distin-
guished from promoters by their specific enrichment of
H3K4m1 (6) and can be classified as active or poised de-
pending on the presence or absence of H3K27ac (45). A
comprehensive study of hematopoiesis in mice revealed
that a significant proportion of lineage-specific enhancers are
established de novo in parallel with H3K4m1 enrichment.
Further, clear distinctions were observed across the respective
enhancer repertoires after the definitive differentiation step
from monocyte to macrophage (71). Enrichment of H3K27ac
during human macrophage differentiation is often accompa-
nied by increased deposition of H3K4m1. By contrast, a ma-
jority of sites that lose H3K27ac retain theirH3K4m1 signature
and remain sensitive to cleavage by DNase I due to their open
chromatin architecture (115).
Epigenomic patterns distinguish training and toler-
ance. Because many studies reporting adaptive characteris-
tics of the innate immune system predate the modern era of
molecular biology, insufficient understanding at the molecular
level meant that the magnitude of this process was perhaps
underappreciated. Although much detail remains to be eluci-
dated, several studies published in recent years demonstrate
the essential role of epigenetic reprogramming in innate im-
mune memory across various phyla (93, 96, 105, 112, 126).
These seminal findings not only shed light on the molecular
mechanisms underlying the capacity for monocytes to inte-
grate micro-environmental experiences into their programs of
gene expression that is a type of chromatin-based memory but
also emphasize the potential reversibility of innate immune
phenotypes (97).
Several studies describe the enrichment of H3K4m3 at
promoters associated with trained immunity, for instance at
genes encoding proinflammatory cytokines and intracellular
signaling molecules after stimulation with b-glucan (106,
115), as well as at promoters of genes implicated in athero-
genesis in cells trained with oxLDL (9). Further, the heter-
ologous benefit of BCG vaccination is associated with
persistent H3K4m3 enrichment at the promoters of genes
encoding TNFa, IL6, and TLR4 (66). Similarly, H3K4m3
distinguishes attenuated (tolerizable) and induced (non-
tolerizable) genes in immune tolerance. Although promoters
of both classes of genes are trimethylated at H3K4 on LPS
stimulation, this mark is selectively maintained at non-
tolerizable promoters after restimulation (40). The positive
correlation of H3K4m3 and transcriptional activity is well
described across various organisms and cell types (6, 72,
114). Accordingly, inhibition of this modification by using
the pan-methyltransferase inhibitor 5¢-methylthioadenosine
(MTA) precludes the adapted phenotypes induced by b-
glucan (50), BCG (66), and oxLDL (9).
Although quantifying H3K4m3 can be informative of
transcriptional competency or activity at discrete loci, it
hardly exhausts the broad regulatory potential for histone
modifications in innate immune memory. Recent deep se-
quencing analyses revealed distinct epigenomic signatures
that are characteristic of trained immunity and tolerance (24,
97, 115). By generating epigenome-wide maps of H3K4m1,
H3K4m3, H3K27ac, and DNase I sensitivity, Saeed et al.
(115) defined distinct clusters of genomic regions reflecting
putative transcriptional regulatory elements. Importantly,
several of these clusters are differentially modulated in b-
glucan training and LPS tolerance. This is most apparent at
*500 promoters that concurrently gain H3K27ac and
H3K4m3 exclusively in b-glucan-trained cells (115). Para-
lleling naive monocytes, b-glucan treatment results in partial
establishment of macrophage-specific regions within the first
24 h of the in vitro training protocol. In contrast, LPS-treated
cells exhibited stunted differentiation and delayed establish-
ment of chromatin marks. This temporal observation is con-
sistent with a failure of LPS-tolerized macrophages to deposit
active histone marks at promoters of tolerized loci in response
to a second LPS stimulation, including genes associated with
lipid metabolism and phagocytic pathways (97).
Most remarkable, however, is the epigenetic distinction
observed across the respective repertoires of distal enhanc-
ers within these phenotypic extremes of the innate immune
memory spectrum (97, 115). LPS and b-glucan pretreatment
induced a distinct set of enhancers generating signal-
dependent differences in gene expression. Some enhancer
regions (1212) show consistent enrichment of H3K27ac
across both treatment conditions, whereas more than 40% of
all dynamic enhancers gain de novoH3K27ac exclusively in
cells trained with b-glucan. On the other hand, acetylation
of a much smaller subset of enhancers is restricted to LPS-
tolerized cells (115). Taken together, these studies suggest
that b-glucan induces comprehensive epigenetic rewiring of
promoters and enhancers, whereas LPS tolerance is charac-
terized by a subtle epigenetic signature closely reflecting that
of naive macrophages.
The epigenome modulating effects of b-glucan were further
exemplified by the exciting finding that it can partially reverse
LPS tolerance. Exposure of LPS-tolerized cells to b-glucan for
24 h in vitro restored their capacity for cytokine production
(97). Importantly, this reversal of immunoparalysis to a more
responsive phenotype was also observed in monocytes isolated
from volunteers with experimental endotoxemia restimulated
with b-glucan ex vivo. The effects of b-glucan were demon-
strated by the reinstitution of the transcriptional response to
LPS at otherwise tolerized genes. This process was associ-
ated with the restoration of H3K27ac at enhancers previ-
ously precluded by LPS exposure, demonstrating the ability
for b-glucan to effectively erase and reprogram innate im-
munememory. These findings indicate that b-glucan-induced
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receptor pathways remain at least partially responsive in
LPS-tolerized cells, and they could lead to novel immuno-
modulatory strategies for the clinical management of sepsis
(97).
DNA methylation in innate immune memory. Despite its
historically robust associations with genome organization and
transcriptional regulation, much less is known about the po-
tential role of DNA methylation in innate immune memory.
Epigenome-wide analyses have demonstrated a general loss of
5mc during ex vivo monocyte to macrophage differentiation
(97, 138). The vast majority of differentially methylated re-
gions occurred at distal enhancers, with only a small fraction
enriched at gene promoters. In terms of macrophage subtypes,
a distinct methylation pattern was observed for LPS-treated
cells. On the other hand, the methylome of b-glucan-treated
cells more closely resembled that of naive macrophages (97).
Similar to its histone counterpart, 5mc is enzymatically re-
versible. The first step of this process requires oxidation of 5mc
by the ten-eleven-translocation (TET) family of dioxygenases
(18) to generate 5-hydroxymethylcytosine (5hmc). This vari-
ant can then be further processed to 5-formylcytosine and 5-
carboxylcytosine—newly characterized epigenetic marks that
appear to be associated with silenced (26), poised (122), or
activated (109) enhancer elements. The importance of 5mc and
5hmc dynamics in the course of innate immune memory re-
mains an open question. The answer necessitates an ability to
accurately distinguish these variants of cytosine methylation.
The method used by the aforementioned study (97), bisulfite
sequencing, is the gold standard for 5mc analysis and in-
volves the conversion of unmethylated cytosine residues to
uracil. Importantly, both 5mc and 5hmc are resistant to bi-
sulfite conversion (121), meaning that DNA demethylation
could be underestimated by using this method. By extension,
such a method of analysis confounds the discovery of 5hmc-
specific functions in genome regulation. To this end, a recent
study highlights advantages and caveats of commonly used
epigenome-wide 5hmc profiling technologies and demon-
strates that the interpretation of 5hmc data is significantly
influenced by the sensitivity of the method used (121).
Transcriptional and epigenetic memory
The biological consequences of this epigenetic repro-
gramming are numerous and varied. Where they intersect is
at the level of transcriptional regulation; however, the precise
mechanisms of this control require further investigation.
Among the catalogue of gene expression changes associated
with innate immune memory is a subset of genes whose
pattern of expression reveals a profound transcriptional
memory. Within this cluster, a broad distinction can be drawn
between genes that are primed for transcriptional activation
and those that are persistently altered.
A recently emerged paradigm of primed transcriptional
memory centers on the induction of de novo or latent en-
hancers (99). In unstimulated macrophages, these genomic
regions are unbound by TFs and are largely devoid of the
histone modifications that are characteristic of distal regu-
latory elements. However, they acquire signature epigenetic
features of enhancers such as an open chromatin architec-
ture marked by H3K4m1 and H3K27ac in response to spe-
cific stimuli. On removal of the activating stimulus, Ostuni
et al. (99) demonstrated the persistence of H3K4m1 de-
spite loss of H3K27ac at a fraction of decommissioned de
novo enhancers. Moreover, the enhancers that retained
the H3K4m1 signature exhibited a stronger response to
rechallenge (Fig. 3). This chromatin-dependent transcrip-
tional memory may at least partly explain the differential
activation of enhancer repertoires, supporting the unique
phenotypic properties adopted by macrophages as a func-
tion of anatomical location (42), and similar mechanisms
are likely to shape chromatin architectures that are asso-
ciated with innate immune memory. Indeed, the dynamics
and genomic locations of H3K4m1-marked enhancers differ
significantly between b-glucan training and LPS tolerance (97).
Further, these findings are reminiscent of previous descriptions
FIG. 3. Latent enhancers prime
a transcriptional memory in
macrophages. Constitutively un-
marked distal regulatory elements
acquire signature epigenetic fea-
tures of enhancers such as an open
chromatin architecture marked by
H3K4m1 and H3K27ac in response
to specific stimuli. On removal of
the activating stimulus, regions that
retain the H3K4m1 enrichment me-
diate a faster and more robust re-
sponse to restimulation, supporting
a role for this specific modification
in the epigenetic memory of mac-
rophages. H3K27ac, H3 histone-
lysine-27 acetylation; H3K4m1, H3
histone-lysine-4 monomethylation.
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of H3K4m1-dependent metabolic memory in monocytes and
other cell types (57).
Contrasting primed memory, persistent memory is charac-
terized by transcriptional activity that is sustained beyond
removal of the activating stimulus. Monomethylation of
H3K4 underlies persistent, high-glucose-mediated pro-
inflammatory gene expression that is refractory to glycemic
correction in vascular endothelial models of glycemic vari-
ability and diabetic mice (17). This epigenetic signature,
written by the Set7 KMT, was later observed in monocytes of
diabetic patients (101). Intersection of the transcriptome data
from early and late timepoints described by Novakovic et al.
(97) reveals a cluster of genes whose transcriptional response
to b-glucan is maintained for 5 days in culture (Fig. 4). This
includes genes downregulated 24 h after stimulation that are
also downregulated on day 6, as well as genes upregulated on
day 1 that remain in a state of heightened transcriptional
activity for the duration of the experiment. Of course, this is a
simplification as the activity of some genes may oscillate
between altered and basal transcriptional states at interme-
diate time points. Nonetheless, this model may provide a
useful framework to understand changes in gene expression
that are associated with metabolic and other pathways that
occur early in the process of trained immunity and support
the phenotype of fully differentiated, trained macrophages.
Discernment of the epigenetic proponents of persistent gene
expression will inform about not only mechanisms that sus-
tain the memories of macrophages but also long-term epi-
genetic programming of myeloid cells.
The heterologous protection conferred by vaccination with
BCG far exceeds the lifespan of innate immune cells in the
circulation (66). The remarkable finding that the trained
phenotype and gene-specific H3K4m3 enrichment can be
observed 3months and even up to 1 year after vaccination has
inspired interest in the physiological mechanisms mediating
innate immune memory at the level of immune progenitor
cells. Myeloid cell progenitors can mediate long-term TLR2-
induced tolerance (146); however, much less is known about
this process in trained immunity. Evolutionary conservation
of innate immune memory across various phyla provides
valuable opportunities to understand this biological process
in humans (60). Using an experimental infection model,
Torre et al. recently demonstrated that the induction of innate
immune memory in planarians (phylum Platyhelminthes) is
driven by a specific population of pluripotent stem cells (126).
Although much controversy surrounds the transmissibility of
histone modifications across generations in vertebrates, the
role of DNA (de)methylation in myeloid differentiation is
actively investigated (2, 137). Further, the heritability and
potent gene-regulating functions of 5mc underscore the en-
thusiasm surrounding the role of this modification in sus-
taining cellular memories (14). Future studies should aim at
characterizing the DNA methylomes of myeloid progenitors
and terminally differentiated cells in the broader context
of innate immune memory.
In light of the epigenetic changes and different modes of
transcriptional memory that define innate immune memory, a
key challenge is to understand the operational epigenetic
machinery (145). Several epigenetic enzymes have been re-
cently associated with macrophage function [recently re-
viewed by Hoeksema and de Winther (45)]; however, their
roles in training and tolerance remain untested. One study
reported significant upregulation of Set7 in response to b-
glucan training (115). Although the importance of the MLL1
KMT to epigenetic enhancer signatures in macrophages has
been recently described for processes such as TLR4 signaling
(56, 65), the potential role of Set7 remains to be established.
As an interesting link to metabolic regulation, genes encod-
ing KDMs JMJD1A and JMJD2B are transcriptionally acti-
vated by HIF1a in response to hypoxia in primary epithelial
cells as well as transformed cell lines (12, 67). In this search
for epigenetic regulators, another potentially important clue
was revealed by the study of Torre et al. (126). The trained
phenotype of planarians is dependent on a KMT that shares
homology with human Set8. This enzyme specifically
methylates lysine 20 on H4 histones (87), a modification that
is yet to be explored in the innate immune memory of ver-
tebrates (60).
Recent evidence suggests that the identities of some of the
factors responsible for the myriad epigenetic changes gov-
erning innate immune memory may be revealed through a
deeper understanding of upstream signaling events that sus-
tain epigenetic pathways and shape the deposition of chro-
matin marks (91).
Epigenetics and immunometabolism
Inhibition of either glycolysis or mTOR signaling inter-
rupts the characteristic chromatin modification pattern and
adapted phenotype of trained immunity, confirming a role for
metabolic changes in epigenetic reprogramming. Further
linkingmetabolic rewiring of cellular metabolismwith innate
immune memory, evidence increasingly supports the inte-
gration of metabolic information and transcriptional control
via the enzymatic consumption of metabolites in epigenetic
reactions (57). Specifically, the enzymatic activities of many
chromatin modifiers are regulated, in part, by concentrations
of metabolic intermediates (32). Fluctuating metabolite
concentrations, therefore, potentiate continual adjustment of
gene expression by modulating the epigenome to influence
chromatin dynamics (57).
FIG. 4. Training with b-glucan induces a program of
persistent transcriptional memory. Persistent transcrip-
tional memory is characterized by transcriptional activity that
is sustained beyond removal of the activating stimulus. In-
tersection of transcriptome data derived from macrophages at
early (24 h) and late (6 days) time points post b-glucan
stimulation described by Novakovic et al. (97) (GSE85246)
reveals a cluster of 121 genes whose transcriptional response
is maintained for the duration of the experiment.
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It is, therefore, reasonable to speculate that the profound
metabolic changes associated with trained immunity could
sustain epigenetic patterns or drive further alterations to the
chromatin landscape at important regulatory regions through
an interesting interplay between metabolites and gene regula-
tion. Critical metabolic intermediates such as NAD+ and
acetyl-CoA, which are altered in b-glucan-trained monocytes
(24, 91), serve as cofactors or substrates for numerous HDACs
and HATs, respectively (Fig. 5). The methylome is also sen-
sitive to metabolic variation through changes to cellular levels
of a-ketoglutarate, an essential cofactor for several lysine and
cytosine demethylating enzymes (57, 82). Importantly, TCA
cycle intermediates succinate and fumarate can inhibit certain
demethylation reactions (143). The striking elevation of suc-
cinate and fumarate induced by the metabolic rewiring of
trained macrophages, therefore, represents a plausible mech-
anism behind the integration of immunometabolic and epige-
netic programs in trained immunity.
Drawing on these molecular interactions, we recently
demonstrated that the accumulation of fumarate as a function
of glutamine replenishment of the TCA cycle connects im-
mune pathways with epigenetic programs by inhibiting the
H3K4 demethylase KDM5, thereby elevating the enrichment
of H3K4me3 at the promoters of genes encoding proin-
flammatory cytokines (5). Moreover, exogenous fumarate it-
self induces a trained macrophage phenotype in terms of
cytokine production that is again abolished by inhibition of
glutaminolysis and glycolysis. At the epigenomic level, fu-
marate training echoes a proportion of the chromatin patterns
induced by b-glucan, implicating its probable involvement in
at least partially mediating the effects of classical training
stimuli. Perhaps most remarkable is the observation that fu-
marate positively regulates transcription of genes encoding
KDM5 isoforms, in addition to the epigenetic activity of these
enzymes. From this interplay emerges a regulatory dichotomy
with relevance for trained immunity: KDM5 activity and the
downstream increases in cytokine production mediated by
fumarate were attenuated by a-ketoglutarate (83).
Another important observation transpiring from this study
was the induction of H3K27ac in cells trained with fumarate
(5). This raises two main possibilities. First, fumarate could
positively regulate the expression of genes encoding HATs
or, reciprocally, negatively regulate HDAC gene expression
by inhibiting demethylation of active chromatin marks. Sec-
ond, fumarate inhibits KDM5 demethylases to regulate the
chromatin-modifying activities ofHATs orHDACs by altering
their post-translational lysine methylation status (Fig. 5).
Finally, other metabolites could directly influence epige-
netic regulation by mechanisms that are yet to be thoroughly
characterized. A pertinent example is succinylation—a post-
translationalmodification of proteins inwhich a succinyl group
is added to a lysine residue from succinyl-CoA (153). In ac-
cordance with the marked increases observed for succinate in
trained immunity, lysine succinylation is considered an in-
flammatory signal for innate immune cells (125). Importantly,
this modification is written to several sites of histone tails in
human and yeast cells (144). Although details of the functional
consequences of histone succinylation are currently un-
described, this modification induces a structural chromatin
change that is greater than the change caused by lysine acet-
ylation, by converting a positively charged residue to a nega-
tive charge (144). Future studies are predicted to strengthen
this regulatory connection between chromatin biology and the
metabolic characteristics of innate immune memory.
Multiple roles for lysine methylation
in innate immune memory
The very definition of epigenetics has drawn its share of
recent criticism (86), though perhaps largely from argument
that is more semantic than biologic and stemming from an
etymology rooted in developmental biology and heredity
(139). It is now clear that epigenetic processes are not only
restricted to roles in development but also shape the pheno-
types of nondividing cells. Certainly more deserving of at-
tention is the controversy surrounding the hierarchical
significance of epigenetic modifications in gene expression.
A stringent interpretation of the histone code hypothesis (51)
tends to attribute regulatory primacy to chromatin modifi-
cations while appreciating that TFs bind specific DNA se-
quences to activate nearby genes. However, rather than
displace the long-standing importance of TFs, the emerging
FIG. 5. Chromatin modifications unite immunometa-
bolism and gene expression. The activities of many
chromatin-modifying enzymes are regulated in part by con-
centrations of intermediates of energy metabolism. Re-
purposing of the TCA cycle modulates the epigenome of
trained immunity. Members of the sirtuin family of HDAC
enzymes are sensitive to intracellular NAD+/NADH ratios.
Acetyl-CoA is the essential acetyl group donor to lysine
acetylation (by HATs), linking intermediary carbon metabo-
lism with chromatin dynamics and transcription. Histone ly-
sine demethylating events are influenced by the elevated
levels of succinate and fumarate that are associated with
metabolic rewiring of trained macrophages. In particular,
fumarate inhibits KDMs, thereby elevating the enrichment
of H3K4m3 at the promoters of genes encoding proin-
flammatory cytokines. H3K4m3, H3 histone-lysine-4 tri-
methylation; TCA, tricarboxylic acid.
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picture is one where epigenetic enzymes and chromatin
modifications synergize with traditional regulators of tran-
scription. To this end, a conceptual framework that en-
compasses the molecular tagging of chromatin components
to designate functional genomic regions and support tran-
scriptional responses to distinct signaling cues is consistent
with the current understanding of gene regulation.
Though not entirely overlooked, the role of TF networks
for the induction of innate immune memory has not received
the same attention as chromatin modifications. Approxi-
mately 12% of known TFs are variably expressed during
macrophage differentiation, tolerance, and training (115).
Further, discrete binding motifs within condition-specific
dynamic epigenomic regions indicate the importance of
particular TFs for the distinct transcriptional programs of
trained and tolerized macrophages (97, 115).
Although pre-treatment with a pan-methylation inhibitor
impedes the epigenetic rewiring and, consequently, blocks
the adapted phenotype of trained cells (9, 50, 66), histones
and DNA are not the only gene-regulating factors modulated
by methylation. Post-translational methylation has in recent
years emerged as a ubiquitous and pivotal determinant of TF
stability and trans-activity, revealing the dual regulatory roles
of KMTs and KDMs in histone-dependent and -independent
mechanisms of transcription (Fig. 6) (22, 70). Similar regu-
latory functions are attributed to post-translational lysine
acetylation (102, 123). Of particular relevance to the induc-
tion of innate immune memory for its potential influence on
cellular metabolism is the post-translational methylation re-
cently shown to regulate HIF1a function. Set7-mediated
methylation of HIF1a diminishes its occupancy on glycolytic
gene promoters, thereby inhibiting gene expression (78).
Importantly, this modification is reversed by lysine-specific
histone demethylase 1 (LSD1) (64), an epigenetic enzyme
that is influenced by cellular levels of flavin adenosine di-
nucleotide and is, therefore, sensitive to metabolic variation
(44). It is currently unknown as to whether similar methyl-
dependent regulation of HIF1a, or other TFs that direct the
overall metabolic shift, impacts the induction of trained
immunity.
This avenue of inquiry could also reveal novel regulatory
mechanisms that are immediately associated with the trained
cell’s response to secondary stimuli. The rapidity and mag-
nitude of macrophage responses to TLR stimulation is facil-
itated by the expeditious deployment of stimulus-responsive
TFs such as AP-1, NFjB, and STAT family members
to regulatory elements of inflammatory genes (91). As de-
scribed earlier, these transcriptional responses are intensified
in trained immunity by the sustained accessibility of chro-
matin owing to specific epigenetic patterns. However, the
same pathways that support chromatin modifications may
also influence TF dynamics. Much like histones, the func-
tional consequences of TF lysine methylation are site specific
(Table 2).
In addition to their interactions with modified histones,
binding of TFs can, in fact, facilitate the localization of
epigenetic enzymes to sites of chromatin modification (58).
A recent finding suggests that the stress-responsive TF ATF7
is a key regulator of long-term maintenance of epigenetic
changes that enhance macrophage resistance to pathogens
(150). In resting cells, ATF7 suppresses a group of innate
immune-related genes by recruiting the H3K9 KMT G9a. In
response to LPS stimulation, ATF7 is phosphorylated by p38
kinase and released from the chromatin. This causes a con-
comitant decrease in transcriptionally repressive H3K9m2
levels, culminating in a partially disrupted chromatin struc-
ture. Once ATF7 is depleted from the chromatin, it is not
entirely reinstated back at the original binding sites, thus
maintaining the expression of target genes for long periods as
a type of epigenetic and transcriptional memory (149, 150).
Interestingly, many chromatin-modifying enzymes are
themselves regulated by post-translational modifications,
including lysine methylation and acetylation, suggesting a
highly ordered and dynamic network of components that
are capable of writing and erasing modifications at both the
chromatin template and each other. For example, the
FIG. 6. Lysine methylation regulates
gene expression by chromatin-dependent
and chromatin-independent mechanisms.
In addition to chromatinized histone sub-
strates, epigenetic lysine methyl writers can
exert their influence on gene expression by
specific methylation of amino acid residues
on the surface of non-histone proteins. The
functional consequences for substrates such
as key transcription factors include changes
in protein stability and activity that modulate
downstream transcriptional outcomes.
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enzymatic activity of a specific HAT known as p300/CBP-
associated factor is post-translationally regulated by meth-
ylation and acetylation at numerous lysine residues (85, 117).
Individual epigenetic enzymes, therefore, possess the po-
tential to indirectly control multiple chromatin modifications.
Mapping the inter-enzyme modification network of chro-
matin regulators has considerable capacity to expand our
understanding of gene regulation (58).
Conclusion and Future Perspective
The defining premise of innate immune memory rests on the
cell’s ability to retain and recall information about previous
exposures. This cellular memory is facilitated by major shifts
in metabolic and transcriptional pathways. It is becoming in-
creasingly clear that such changes are inextricably and bi-
directionally linked through epigenetic mechanisms. These
findings add to the growing body of literature supporting a
prominent role for the epigenome in recording adaptive ex-
periences. In particular, they shed light on the potential
mechanisms underlying primed and persistent transcriptional
memory in innate immune training and tolerance. Further,
stable and heritable epigenetic changes have the capacity to
explain the long-term memory effects of trained immunity
observed months after BCG vaccination (66).
Trained immunity is a fundamental property of the mam-
malian immune response, and it is increasingly investigated
as an adjuvant to potentiate next-generation vaccines (79). In
recent years, there has been a shift by some in the field to
understand the broader therapeutic possibilities. For exam-
ple, inducers of trained immunity such as BCG and b-glucan
represent current (19, 89) and prospective approaches to the
clinical management of various cancers. The restoration of
cytokine production in experimental endotoxemia by b-
glucan at the level of histone modification and transcriptional
reactivation highlights the potential of epigenetic therapy in
the broader context of immune paralysis (97). On the other
hand, innate immune reprogramming may have adverse ef-
fects in various pathological contexts, particularly under
chronic inflammatory conditions in which trained immunity
is induced by endogenous ligands. The enhanced and mala-
daptive immune responsiveness foreshadows important
consequences as well as novel therapeutic opportunities for
the development, progression, and stability of atherosclerotic
lesions (27). Further exploration may uncover new clinical
strategies to treat vascular complications arising from the
deleterious hyperactivity of innate immune cells sustained by
features of metabolic syndrome and the diabetic milieu (135).
Indeed, hyperglycemia can induce long-term epigenetic
modulation of inflammatory gene expression (23, 101).
Clinical exploitation will be enhanced by the rapidly ac-
cumulating knowledge of the molecular mechanisms under-
lying the metabolic and epigenetic rewiring of adaptive
innate immune responses. Pharmacological modulation of
metabolism has shown potential in other pathophysiological
situations. For example, inhibition of glycolysis limits path-
ological neovascularization (118). The emerging picture of
trained innate immunity outlines a process driven by complex
interactions between metabolic and epigenetic factors. Not
surprisingly, the immune-modulating effects of metabolic
inhibitors are, at least partly, mediated by epigenetic changes.
Such studies have already disclosed important clues to the
identities of the nuclear machinery responsible for main-
taining chromatinized signatures of innate immune memories
(5), providing an early framework for the development of
clinical strategies that target epigenetic regulators. Several
drugs that inhibit epigenetic enzymes are already approved
for clinical use in the fields of oncology and hematology
(104). Small-molecular histone mimic BET inhibitors (iBET)
have shown promise for treatment of inflammation (95).
Though effective in blocking LPS-induced tolerance when
co-administered in human monocytes, iBET treatment was
unable to reverse memories of previous LPS stimulation (97).
While offering arguably greater precision for the adjust-
ment of discrete transcriptional events, direct pharmacolog-
ical manipulation of the epigenetic proponents of trained
immunity raises some important considerations. As described
earlier for the pan-methyl inhibitory properties of MTA,
certain HDAC inhibitors exhibit broad substrate specificity.
Even compounds that target specific enzymes may have un-
intended effects, as the complex interplay between epigenetic
enzymes and traditional transcriptional machinery forecasts
the potential pleiotropic impact of epigenetic drugs across a
broad spectrum of protein substrates and gene regulatory
processes (77, 107). The complexities of pharmacological
epigenetic modulation are further exacerbated by cell-type-
Table 2. Lysine Methylation Regulates Transcription Factor Function
Transcription factor Methylated lysine Regulatory function KMT KDM
HIF1a K32 Repression Set7 (64, 78) LSD1 (64)
K391 Degradation LSD1 (74)
NFjB-p65 K37 Activation Set7 (34)
K218 Activation NSD1 (84) FBXLII (84)
K221 Activation NSD1 (84) FBXLII (84)
K310 Repression SETD6 (76)
K314 Degradation Set7 (148)
K315 Degradation Set7 (148)
STAT3 K49 Activation EZH2 (31)
K140 Repression Set7 (147) LSD1 (147)
K180 Activation EZH2 (63)
STAT1 K685 (predicted) Set7 (61)
HIF1a, hypoxia-inducible factor 1-alpha; KDM, lysine demethylase; KMT, lysine methyltransferase; LSD1, lysine-specific histone
demethylase 1.
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specific roles of the chromatin-modifying machinery. For
example, macrophage and endothelial cell HDAC3 play op-
posing roles in the development of atherosclerosis in mice
(46, 152). For these reasons, recent technological and sci-
entific advances such as single-cell transcriptomic and epi-
genomic profiling will form the cornerstone of future
research efforts.
Indeed, we are only beginning to scratch the surface of a
remarkably intricate system of long-term gene regulation and
transcriptional memory. In combination with DNA sequence
profiling, epigenomics could determine the functional sig-
nificance of genetic variants to innate immune function (19),
including those occurring in regulatory and noncoding re-
gions. Epigenomic and transcriptomic profiling could also
unravel the contributions of miRNA and lncRNA to trained
immunity, which remain largely unexplored but are of sig-
nificant regulatory potential (91). Further, TF substrates of
epigenetic enzymes can be inferred from chromatin and gene
expression profiles and protein substrate motifs (61). Suc-
cessful future therapeutic approaches to the manipulation of
innate immune memory of infectious and autoinflammatory
diseases will emerge only from a comprehensive under-
standing of key molecular events and epigenetic interactions.
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Abbreviations Used
b-glucan¼ b-1,3-(D)-glucan
5hmc¼ 5-hydroxymethylcytosine
5mc¼ 5-methylcytosine
BCG¼Bacillus Calmette–Gue´rin
BET¼ bromodomain and extra-terminal
CpG¼ 5¢-cytosine-phosphate-guanine-3¢
dinucleotide
H3K27ac¼H3 histone-lysine-27 acetylation
H3K4m1¼H3 histone-lysine-4 monomethylation
H3K4m3¼H3 histone-lysine-4 trimethylation
HAT¼ histone acetyltransferase
HDAC¼ histone deacetylase
HIF1a¼ hypoxia-inducible factor 1-alpha
iBET¼BET inhibitors
KDM¼ lysine demethylase
KMT¼ lysine methyltransferase
lncRNA¼ long noncoding RNA
LPS¼ lipopolysaccharide
LSD1¼ lysine-specific histone demethylase 1
MAMP¼microbe-associated molecular pattern
miRNA¼micro RNA
MTA¼ 5¢-methylthioadenosine
mTOR¼mechanistic target of rapamycin
oxLDL¼ oxidized low-density lipoprotein
OXPHOS¼ oxidative phosphorylation
PPP¼ pentose phosphate pathway
TCA¼ tricarboxylic acid
TF¼ transcription factor
TLR¼Toll-like receptor
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